Search

everythinglearnresearchcommunity

for

Search:↓

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

Pregnenolone might help manage movement issues caused by Parkinson's disease treatment without reducing the medicine's effectiveness.

Blocking androgen receptors early in life increases estrogen levels and reduces sexual motivation in male rats.

Agomelatine may help reduce benign prostatic hyperplasia by blocking certain inflammatory pathways.

Changing the 6-position on benzopyran molecules affects insulin release, with some compounds showing strong inhibitory effects.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

In late pregnancy, allopregnanolone reduces stress responses in rats by affecting brain chemicals.

Dopamine agonists like pramipexole and ropinirole can cause reversible hair loss.

Four-amino acid part makes enzyme sensitive to finasteride.

Combination drug therapies are more effective for high-risk BPS patients but have more side effects and costs.

Disruption of glycinergic circuits increases pain sensitivity, suggesting new pain treatment options.

Long-term antiandrogen use may increase aggressive prostate cancer risk.

FOL-005 peptide may help treat excessive hair growth safely.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Some postmenopausal women with frontal fibrosing alopecia stopped losing hair with finasteride treatment, hinting at a possible hormonal cause.

A brominated phenoxy compound effectively inhibits a human enzyme and shows potential for clinical use.

Prostaglandin analogue may help with eyebrow loss in frontal fibrosing alopecia.

5-alpha-reductase inhibitors help treat urinary symptoms from an enlarged prostate.

Finasteride helps hair regrowth in frontal fibrosing alopecia.

GnRH analogue can help diagnose ovarian causes of high testosterone in postmenopausal women when scans don't show the cause.

Therapies targeting the androgen receptor are being developed to treat prostate cancer and improve bone and muscle health.

Potassium channel openers show promise for treating heart disease and other conditions, but more research is needed to fully understand their effects and safety.

Current treatments for lower urinary tract symptoms include α1-blockers, 5ARIs, PDE5 inhibitors, anticholinergic agents, and β3-adrenergic receptor agonists.

14,15-EET may help reduce poststroke pain by affecting certain brain proteins.

PPAR-γ helps control skin oil glands and inflammation, and its disruption can cause hair loss diseases.

CRTH2 antagonists might be useful for treating many conditions because they play a role in immune and inflammation responses.

A new topical treatment for hair loss shows strong hair growth effects with low toxicity.

Combining a GnRH agonist with a low-dose oral contraceptive is more effective and safer for treating hirsutism than using either alone.

Finasteride slows down motherly behavior in first-time pregnant rats.